fbpx Skip to main content

Public Policy Newsletter Article

Government Continues to Respond to COVID-19 Pandemic

  • 2020-06-18T13:00:00.000+0000
  • California
  • Author: Jimmy Jackson

As we enter the fourth month of the pandemic shutdown, the Public Policy Department continues to keep our members provided with the latest and most important updates on the fast-moving county, state and federal developments that will affect our members, while also engaging on the other policy matters most important to our members.

We would be remiss if we did not acknowledge the change of this year’s BIO International Convention, which was scheduled for a return to San Diego, to an all-digital model due to current gathering restrictions. The BIO Convention team pivoted to present a fantastic program. In case you didn’t “attend,” here are seven things we learned at the BIO 2020 Digital Convention.

An important lifeline utilized by many Biocom members was the recently enacted federal Paycheck Protection Program (PPP), which offered assistance and incentives for companies who kept their workers on the payroll. Recent changes signed into law relax some requirements for companies eligible to participate in the PPP, including more time and flexibility to qualify for loan forgiveness, less stringent payroll expenses requirements, and ability to defer payroll taxes, among others.

On the regional policy level, Biocom continues to keep its members abreast of the latest orders in each of the largest life science clusters we service. The policy department also continues to provide exceptional committee-driven content by our members for their peers. On June 23, our San Diego Facilities Committee will present a virtual workshop on Facility Adaptation for COVID-19. Separately tailored events will be developed for our members in Los Angeles and the Bay Area.

In Sacramento, it is critical that lawmakers understand the challenges and opportunities of the industry. Biocom was proud to co-host a Sacramento virtual briefing by Assembly Speaker pro Tem Kevin Mullin and the California Biotechnology Foundation on May 28. More than 50 legislators and staff tuned in to discuss novel COVID-19 testing, therapies and vaccines. Meanwhile, Biocom is working with our Sacramento partners to try to fight proposals to limit utilization of research and development credits and suspend net operating loss credits for 3 years.